| Document |
Document Title |
|
WO/2024/096389A1 |
The present invention relates to a composition for preventing, ameliorating or treating cognitive dysfunction or Alzheimer's disease comprising, as an active ingredient, Lactobacillus fermentum SRK414 strain which has accession number KC...
|
|
WO/2024/097713A1 |
In one embodiment, the present disclosure provides hypoallergenic peanut allergens Ara h 6 variants wherein at least one epitope recognized by anti-Ara h 6 antibodies has been modified, thereby having reduced or abolished antibody bindin...
|
|
WO/2024/096656A1 |
The present invention relates to a composition including catechin hydrate as an active ingredient for the prevention, alleviation, or treatment of chronic obstructive pulmonary disease. The catechin hydrate of the present invention signi...
|
|
WO/2024/094523A1 |
The present disclosure generally relates to mogroside compositions useful for improving the flavor of certain fruit juice compositions that have certain undesirable flavors, such as excessive astringency, bitterness, or sourness, or insu...
|
|
WO/2024/096818A1 |
The present disclosure relates generally to compositions for enhancing mental wellbeing, particularly compositions from plant extracts for use in calming energizing or enhancing happiness or euphoria in individuals. Methods disclosed inc...
|
|
WO/2024/095311A1 |
The present invention relates to a food composition, a cosmetic composition, or a drug composition that contains an ascorbic acid 2-glucoside basic amino acid salt and an ascorbic acid 2-glucoside alkali metal salt. A composition accordi...
|
|
WO/2024/096842A1 |
The invention relates to a production method involving steps to provide probiotic content in dried figs rich in dietary fiber while delaying the onset of surface crystallization throughout their shelf life. The steps include obtaining dr...
|
|
WO/2024/095279A1 |
The present invention discloses synergistic herbal compositions comprising combination of a first ingredient selected from Centella asiatica extract containing at least one component selected from magnesium salt or complex of asiatic aci...
|
|
WO/2024/096874A1 |
An organic base, including: a solid powder; wherein the solid powder is derived from marine algae; wherein the solid powder is freeze dried; and wherein the solid powder is at least partially water soluble.
|
|
WO/2024/096445A1 |
The present invention relates to a composition for ameliorating, preventing, or treating stress and depression-related diseases, the composition containing talampanel. The talampanel in the present invention has excellent antidepressant ...
|
|
WO/2024/095303A1 |
The purpose of the present invention is to provide a composition that can improve, suppress reduction of, or maintain energy production, that is effective in improving, suppressing reduction of, or maintaining energy production, and that...
|
|
WO/2024/094481A1 |
The present invention concerns a microorganism comprising at least one gene coding for a protein having the function of a L-arginine:glycine amidinotransferase and having an increased activity of a transmembrane exporter protein and to a...
|
|
WO/2024/096140A1 |
The present invention relates to a jelly preparation agitation device which can effectively agitate, in an agitation pot, a mixture of ingredients for preparing jelly, and which comprises the agitation pot, an agitation part and a motor ...
|
|
WO/2024/096214A1 |
A composition containing gomisin G as an active ingredient, according to the present invention, has been confirmed to inhibit protein expression of myostatin, atrogin1, MuRF1 which are involved in muscle degradation, and it has been conf...
|
|
WO/2024/094483A1 |
The present invention concerns a microorganism comprising at least one gene coding for a protein having the function of a L-arginine:glycine amidinotransferase and having an increased activity of a rt protein belonging to the Amino Acid-...
|
|
WO/2024/095992A1 |
The present invention addresses the problem of providing a novel means for suppressing renal hypofunction, the means being capable of fundamentally improving diseases associated with renal hypofunction, including chronic kidney disease (...
|
|
WO/2024/095906A1 |
The purpose of the present invention is to provide a composition or the like for preventing or inhibiting inflammation of neural cells. The present invention relates to a composition for preventing or inhibiting inflammation of neural ce...
|
|
WO/2024/094776A1 |
Method for the preparation of a beverage for a subject from a formula product (10) comprising the steps of i. obtaining the formula product (10) with a default ratio (40) wherein the formula product (10) needs to be mixed with a liquid (...
|
|
WO/2024/094605A1 |
A composition contains a combination of at least one fiber and at least one probiotic and is formulated for administration to a subject in a condition of challenged gut microbiome such that the combination of at least one fiber and at le...
|
|
WO/2024/096094A1 |
The present invention addresses the problem of providing: an oil-in-water emulsion for a blended food that makes it possible to prepare a blended food that is imparted with energy and reduces a feeling of sticking inside the mouth when e...
|
|
WO/2024/096354A1 |
The present invention relates to a pharmaceutical composition for preventing or treating kidney cancer comprising an IFITM3 inhibitor. According to a composition according to one aspect, the tumorigenesis inhibitory effect can be induced...
|
|
WO/2024/096604A1 |
The present invention relates to a cosmetic composition for skin improvement comprising a fermented aronia extract as an active ingredient. Particularly, the fermented aronia extract according to the present invention can be useful for s...
|
|
WO/2024/096350A1 |
The present application relates to a grilled fish production method comprising a step for pre-treating fish using an alkaline agent, and to grilled fish having improved texture produced by the method.
|
|
WO/2024/096886A1 |
The covid-19 coronavirus has killed more than 5,129,829 people, globally, out of about 255,098,687 infected. About 10 million persons died from cancer in 2020, with 19.3 new cases diagnosed. About 409,000 persons died of malaria in 2019....
|
|
WO/2024/095016A1 |
The invention relates to non-cocoa or cocoa-free chocolate analogues and methods for making such analogues. The invention also extends to fermentation methods for producing cacao/cocoa-free chocolate analogues and to foodstuffs and cosme...
|
|
WO/2024/096059A1 |
The present invention addresses the problem of providing a water-filled seamless capsule technology that can encapsulate and retain the moisture of a content liquid in a capsule over a long period of time. A water-filled capsule compri...
|
|
WO/2024/096132A1 |
The purpose of the present invention is to provide: a sweetness and/or flavor enhancer which makes it possible to obtain a feeling of satisfaction when eating even when the amount of sugar in a food/beverage product has been reduced; a f...
|
|
WO/2024/092983A1 |
Disclosed is a method for preparing a polymorphic resistant starch. The method uses high-amylose maize starch as the raw material and plasma-activated water with a pH value of 4-5 for formulating a high-concentration starch emulsion; by ...
|
|
WO/2024/096034A1 |
Provided is a technique for improving the flavor of food. The flavor of a food product is improved by using a yeast fermentation product of a plant belonging to the family Solanaceae, such as a tomato.
|
|
WO/2024/097601A1 |
The present technology provides a method for feeding swine, the method includes: feeding swine a swine feed that includes a nitrate compound, hydrates thereof, salts thereof, or combinations thereof, and optionally an antioxidant that in...
|
|
WO/2024/096185A1 |
The present disclosure relates to: a complex fermentation product of a mixture containing tangerine peel, mushroom, and, optionally, apple mango; a composition, in particular a health functional food composition, for appetite suppression...
|
|
WO/2024/096280A1 |
The present invention relates to a composition for preventing, ameliorating, or treating Alzheimer's disease, comprising, as active ingredients, a Vitis vinifera stem extract and a compound isolated therefrom. The active ingredient of th...
|
|
WO/2024/095804A1 |
The present invention provides: a storage deterioration suppressing agent for suppressing the deterioration in flavor of a food or a beverage that is intended to be stored for a certain period of time at a temperature ranging from 0°C t...
|
|
WO/2024/097749A2 |
The present disclosure relates to cultured tissue, methods for production of self-sufficient modified cells for producing cultured tissue. Further, the disclosure provides methods of generating cultured meat products without exogenous ad...
|
|
WO/2024/095050A1 |
A Herbal Tea for Type II diabetes mellitus patient is made by a specific method mentioned in the Fig. 1 and Fig 2 of the drawing from Gymnema lactiferum leaf used in this randomized double-blind controlled clinical trial. 320 Type II Dia...
|
|
WO/2024/094891A1 |
The invention relates to a method for producing a protein-containing food or animal feed, comprising the following steps: providing a mouldable base mass, comprising at least one secondary flow from the food industry, wherein the mouldab...
|
|
WO/2024/096064A1 |
The present invention provides an oral composition for repelling insects, said oral composition containing 0.01-1 wt % of citral, and including citric acid or a salt thereof, and acesulfame K or sweetener having a sweet aftertaste.
|
|
WO/2024/097612A1 |
Described herein is a food product comprising: a fat in an amount of about 5 wt.% to about 15 wt.%; a humectant in an amount of about 5 wt.% to about 35 wt.%; a protein in an amount of about 2 wt.% to about 20 wt.%; a fibre in an amount ...
|
|
WO/2024/096091A1 |
[Problem] To provide an agent which is safe even when ingested for a long period and can improve the intestinal microflora of a dog. [Solution] This agent for improving the intestinal flora of a dog contains nicotinamide mononucleotide a...
|
|
WO/2024/096135A1 |
[Problem] The purpose of the present invention is to provide: an oil- and fat-containing gel having the mouthfeel of oozing oil and fat when chewed; a production method for the oil- and fat-containing gel; and a food product including th...
|
|
WO/2024/096136A1 |
[Problem] The objective of the present invention is to provide: a fat-containing gel providing a texture of fat oozing during chewing; a method for producing the fat-containing gel; or a foodstuff containing the fat-containing gel. [Solu...
|
|
WO/2024/094548A1 |
The present invention relates to a process for roasting coffee, in particular to roasting extracted green coffee at elevated pressure followed by roasting at lower pressures. Further aspects of the invention are a roast coffee and a cont...
|
|
WO/2024/093625A1 |
The present invention relates to the technical field of biomedicine. Disclosed is a linolenic acid-derived ceramide, which has a structure of general formula I or an isomer of general formula I: (I), wherein R1 is selected from (II) or (...
|
|
WO/2024/096261A1 |
The present invention relates to a pharmaceutical composition for treating or preventing autoinflammatory diseases, comprising, as an active ingredient, TLR inhibitor peptide 1 (TIP-1) or MAL/MyD88 inhibitory peptide 2 (MIP-2) or a polyn...
|
|
WO/2024/094232A1 |
The present invention consists of a solid nutraceutical composition to prevent and treat cognitive impairment, formed by mixing an emulsion and a seed and oil mass, the components of which are of natural origin. The emulsion contains Plu...
|
|
WO/2024/094754A1 |
The present invention relates to a confectionary mass comprising at least one plant protein source and a method for predicting the behaviour of a powdered protein source in a confectionary mass. The confectionary mass allows for the prod...
|
|
WO/2024/095954A1 |
Provided is cooked rice or a cooked rice processed food in which aging is suppressed. A method for manufacturing cooked rice or a cooked rice processed product in which aging is suppressed, the method including a step for treating a st...
|
|
WO/2024/093141A1 |
A xylanase mutant having a high specific activity. The mutant comprises at least one mutation site of T69A/H, V85D, N88I/M/V/F/H/Y, V108L/M/T/H/I, I112V, H131L/I/W/Y/F, T149V/I/K/L/M/N/R/S/W/Y, D154M/Q/A/I/L/N/S/T/W, N160K/I/T, Q167T, S1...
|
|
WO/2024/098059A2 |
Apparatus, systems, and methods for forming a folded extrudate with improved organoleptic properties. The apparatus for forming the extrudate includes a body defining a flow path extending from an inlet at an upstream end of the body to ...
|
|
WO/2024/096644A1 |
The present invention relates to a composition for preventing, alleviating or treating cognitive impairment or Alzheimer's disease, comprising a Lactobacillus delbrueckii subsp. lactis strain as an active ingredient. The present inventio...
|
